ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
2.670
-0.010 (-0.37%)
At close: Jul 1, 2025, 4:00 PM
2.720
+0.050 (1.87%)
After-hours: Jul 1, 2025, 7:54 PM EDT
ADC Therapeutics Employees
As of December 31, 2024, ADC Therapeutics had 265 total employees, including 263 full-time and 2 part-time employees. The number of employees decreased by 9 or -3.28% compared to the previous year.
Employees
265
Change (1Y)
-9
Growth (1Y)
-3.28%
Revenue / Employee
$286,102
Profits / Employee
-$565,442
Market Cap
264.81M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 265 | -9 | -3.28% |
Dec 31, 2023 | 274 | -43 | -13.56% |
Dec 31, 2022 | 317 | 5 | 1.60% |
Dec 31, 2021 | 312 | 104 | 50.00% |
Dec 31, 2020 | 208 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ADCT News
- 11 hours ago - ADC Therapeutics Makes Grant to New Employee Under Inducement Plan - PRNewsWire
- 15 days ago - ADC Therapeutics Announces Updated ZYNLONTA® Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant Lymphoma (ICML) - PRNewsWire
- 19 days ago - ADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 2028 - PRNewsWire
- 19 days ago - ADC Therapeutics Announces Updated Data from LOTIS-7 Clinical Trial Presented at the European Hematology Association 2025 Congress - PRNewsWire
- 4 weeks ago - ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - PRNewsWire
- 6 weeks ago - ADC Therapeutics to Present at Upcoming Investor Conferences - PRNewsWire
- 6 weeks ago - ADC Therapeutics SA (ADCT) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - ADC Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update - PRNewsWire